Search Within

Niamh Marie Keegan

Formats
  1. Meeting Abstract (10)
  2. Journal Article (7)
  3. Review (2)
Groups
  1. GME, Medicine (19)
  2. Graduate Medical Education (19)
  3. Department of Medicine (18)
  4. Solid Tumor Oncology Division (18)
  5. Genitourinary Oncology Service (17)
  6. Hematology-Oncology Fellows (12)

More Groups

People
  1. Howard Scher (8)
  2. Emily Carbone (7)
  3. Ethan Barnett (7)
  4. Gopakumar Iyer (6)
  5. Jonathan Rosenberg (6)
  6. Samuel Funt (6)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (1)
  4. 2022 (5)
  5. 2021 (4)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Annals of Oncology (2)
  3. Cancer Medicine (1)
  4. Cancer Research (1)
  5. ESMO Open (1)
  6. European Urology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (8)
  2. Oxford University Press (2)
  3. American Association for Cancer Research (1)
  4. American Association for the Advancement of Science (1)
  5. Elsevier B.V. (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (19)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-world clinical outcomes of sacituzumab govitecan after prior exposure to enfortumab vedotin in patients with metastatic urothelial carcinoma
    Journal Article

    Sternschuss, M.; Toumbacaris, N.; Das, J. P.; Powles, T.; Kotecha, R. R.; Laccetti, A. L.; Xiao, H.; Feld, E.; McHugh, D. J.; Keegan, N. M.; more...
    ESMO Open (2025)

    Fulltext@MSK | Save
  • Clinical outcomes of patients with metastatic urothelial carcinoma (mUC) discontinuing enfortumab vedotin (EV) monotherapy (mono) without disease progression
    Meeting Abstract

    Sternschuss, M.; Whiting, K.; Teo, M. Y.; Bajorin, D.; Kotecha, R.; Laccetti, A. L.; Xiao, H.; Feld, E.; McHugh, D. J.; Keegan, N.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Clinical outcomes of sacituzumab govitecan (SG) after prior exposure to enfortumab vedotin (EV) in patients with metastatic urothelial carcinoma (mUC)
    Meeting Abstract

    Sternschuss, M.; Toumbacaris, N.; Das, J. P.; Powles, T.; Bajorin, D. F.; Kotecha, R. R.; Laccetti, A. L.; Xiao, H.; Feld, E.; McHugh, D. J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Correlation of peripheral blood monocytic myeloid-derived suppressor cells (M-MDSC) and T-cell receptor (TCR) dynamics with clinical outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with nivolumab (NIVO)
    Meeting Abstract

    Gupta, A.; Whiting, K.; Keegan, N. M.; Schmalz, J.; Al-Ahmadie, H. A.; Regazzi, A. M.; McCoy, A. S.; Maher, C. A.; Iyer, G.; Rosenberg, J. E.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase I/II study of talazoparib and axitinib in patients with advanced clear cell renal cell carcinoma
    Meeting Abstract

    Kotecha, R. R.; Doshi, S. D.; Knezevic, A.; Jacobi, R.; Aggen, D. H.; McHugh, D. J.; Shah, N. J.; Carlo, M. I.; Keegan, N. M.; Gayadin, Y.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Analysis of BRCA2 copy number loss and genomic instability in circulating tumor cells from patients with metastatic castration-resistant prostate cancer
    Journal Article

    Barnett, E. S.; Schultz, N.; Stopsack, K. H.; Lam, E. T.; Arfe, A.; Lee, J.; Zhao, J. L.; Schonhoft, J. D.; Carbone, E. A.; Keegan, N. M.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • Chromosomal instability (CIN) in circulating tumor cells (CTC) predicts for taxane sensitivity in metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Keegan, N. M.; Arfe, A.; Barnett, E.; Cohn, E. D.; Zhao, J.; Carbone, E.; Zanone, M.; Anderson, A.; Wenstrup, R.; Scher, H. I.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Genomic alterations and evolution in patients with prostate cancer with histologic evidence of neuroendocrine differentiation
    Meeting Abstract

    Barnett, E.; Carbone, E.; Keegan, N. M.; Vasselman, S. E.; Nweji, B.; Zaidi, S.; Scher, H. I.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality
    Journal Article

    Keegan, N. M.; Vasselman, S. E.; Barnett, E. S.; Nweji, B.; Carbone, E. A.; Blum, A.; Morris, M. J.; Rathkopf, D. E.; Slovin, S. F.; Danila, D. C.; more...
    Prostate (2022)

    Fulltext@MSK | Save
  • Spine pain and metastatic prostate cancer: Defining the contribution of nonmalignant etiologies
    Journal Article

    Ruppert, L. M.; Cohn, E. D.; Keegan, N. M.; Bacharach, A.; Woo, S.; Gillis, T.; Scher, H. I.
    JCO Oncology Practice (2022)

    Fulltext@MSK | Save